Abstracts

1125 – Tracking Equitable Rollout of Doxy-PEP and CAB-LA for STI & HIV Prevention in San Francisco Clinics

Background Groundbreaking innovations in prevention of syphilis, chlamydia, and gonorrhea (STIs) with doxycycline postexposure prophylaxis (doxy-PEP) and HIV with long-acting cabotegravir (CAB-LA) have the potential to reduce population-level incidence of STIs and HIV. For maximal effectiveness, these tools must reach those with high STI and HIV rates. In San Francisco (SF) in 2024, STI rates…

966 – Improving Rates of HIV Screening in the Emergency Department Through Clinical Decision Support (CDS)

Background Sexually transmitted infections (STI) disproportionally impact marginalized populations in the US. The Centers for Disease Control (CDC) recommends that persons screened for or diagnosed with an STI receive comprehensive screening for gonorrhea (GC), chlamydia (CT), syphilis, and HIV. STI evaluation is common in emergency departments (ED), yet rates of comprehensive screening in EDs remain…

457 – Genetic Influence on CSF and Plasma Biomarker Stability Over 12 Years in People With HIV

Background People with HIV (PWH) on effective antiretroviral therapy (ART) can have persistent inflammation and neurodegeneration. We have found that some biomarkers are highly stable over 12 years in PWH. Intra-individual differences in host genetics could be responsible by establishing biological set points. We hypothesized that specific single-nucleotide polymorphisms (SNPs) in neurodegeneration and inflammation-related genes significantly influence long-term biomarker stability, defined…

995 – Ganglioside GM3 Functionalized Nanoparticles for Sustained Preexposure Prophylaxis (PrEP)

Background Effective PrEP strategies have stringent pharmacological requirements, including high potency, a long half-life that reduces the need for daily dosing, robust tissue penetration both at HIV transmission sites, such as rectal and vaginal mucosa, as well as secondary lymphoid tissue, and low toxicity. Antiretroviral (ARV) loaded nanoparticles (NPs) that selectively target macrophages and install…

257 – RNA Sequencing of CD4+ T Cells Reveals Similarities in Aging With and Without ART-Suppressed HIV

Background People living with HIV (PLWH) on effective antiretroviral therapy (ART) continue to experience persistent immune activation and chronic inflammation in the absence of detectable viremia. This dysregulation contributes to increased risk of age-related comorbidities, which occur earlier and with higher frequency in PLWH compared to people without HIV (PWOH). It remains unclear, however, whether…

1044 – Doxy-PEP Knowledge, Attitudes, and Practices Among HIV and PrEP Providers: A Pilot Study

Background Doxycycline post-exposure prophylaxis (doxy-PEP) effectively prevents bacterial STIs among men who have sex with men (MSM) and transgender women (TGW). The real-world impact of doxy-PEP will depend partly on provider willingness to prescribe, yet data on provider knowledge, attitudes, and practices (KAP) remain limited. Methods We conducted a cross-sectional pilot survey (May–September 2025) among…

615 – Point-of-Care HCV RNA Compared to Laboratory-Based HCV RNA in a Tribal Health Setting

Background American Indian/Alaska Native (AI/AN) people experience disproportionately high rates of hepatitis C virus (HCV) infection. In 2024, an FDA-approved point-of-care (PoC) HCV RNA test was integrated into community-based screening efforts within Cherokee Nation to expand access and improve linkage to care for underserved, high-risk individuals. The objective of this study is to assess how PoC versus laboratory-based…

343 – Gut Microbiome Is Linked to Intact HIV-1 Reservoir Size

Background The gut microbiome is altered during HIV infection, driving immune dysfunction and inflammation in people with HIV (PWH) that persists despite antiretroviral therapy (ART). In this study, we explored the associations between the gut microbiome composition, the metabolic pathways and the intact HIV-1 reservoir size in PWH on effective ART. Methods Blood and fecal…

646 – Association of HIV Reservoir With Subclinical Myocardial Dysfunction in People With HIV

Background People with HIV remain at higher cardiovascular risk despite long-term ART. Subclinical myocardial impairment, often missed by conventional echocardiography, can be detected using strain-derived myocardial work indices. We aimed to assess early myocardial dysfunction in PWH and its relationship with the HIV reservoir to better understand the higher cardiovascular risk in this population. Methods…